amrutanjan
amrutanjan healthcare
target 1100 by mid 2022
small cap moated company with capex plans enforcing reinvestment moat hence sales and roce are increasing
target 1100 by mid 2022
small cap moated company with capex plans enforcing reinvestment moat hence sales and roce are increasing
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.